Marktanalyse - Mylan Inc.: PharmaVitae Profile

Introduction

The analysis examines the historical and forecast performance for Mylan in the generic prescription pharmaceutical sector. The profile encompasses global company strategy and assessment of financial performance.
Features and benefits

* Gain insight in to Mylan's stategic outlook across the next 6 years.* Analyze company sales forecasts by therapy area, geography and formulation.
Highlights

Strategic insight into the prospects for Mylan over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales
Your key questions answered

* Benchmark Mylan's performance against key rivals in the generic prescription pharmaceutical sector.* See how the acquisition of Merck KGaA's generics unit continues to re-shape Mylan's business

Executive Summary

Key findings

Prescription pharmaceutical sales and growth rate performance, 2005—15

Financial performance, 2005—15

Mylan: PharmaVitae forecasts at a glance

Strategic insight

Impact of M&A over 2003-2015

SWOT analysis

Strengths

Weaknesses

Opportunities

Threats

ABOUT THIS PROFILE

PharmaVitae Explorer database

Chapter structure

Quarterly update

Company introduction

Company sales

Company financials

Key products

Data sourcing

Analyst consensus

QUARTERLY NEWS UPDATE

Latest quarterly sales

Latest prescription pharma product news

Q3 2010

Q2 2010

Q1 2010

Latest corporate news

Q3 2010

Q2 2010

Q1 2010

Q4 2009

Q3 2009

COMPANY INTRODUCTION

Key findings

Background

Key corporate developments

M&A history

Early M&A boosts branded Prescription pharmaceuticals capacity

Matrix acquisition provides API capabilities

Acquisition of Merck Generics

Mylan— potential for further M&A?

Current corporate structure

Generics Segment

Specialty Segment

Matrix Segment

COMPANY SALES

Key findings

Prescription pharmaceutical sales and growth rate analysis, 2009—15

Branded and generic portfolio sales analysis

Therapy area analysis

Geographic analysis

Formulation analysis

COMPANY FINANCIALS

Key findings

Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003—09

Operating costs and profit analysis

Operating costs and profit analysis, 2003-09

OPERATING COST RATIO AND PROFIT MARGIN ANALYSIS, 2003-09

Operating cost ratio and profit margin analysis, 2009—15

Operating costs and profit analysis, 2009-15

KEY BRANDED PRODUCTS

Product portfolio

APPENDIX

Abbreviations

• Global Medical Dressing Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries
• ICT budget forecasts in Large Danish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Large Finnish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Medium-sized Danish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Medium-sized Finnish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Small Danish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Small Finnish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• Global Medical Dressing Market
• Global Medication Management System Market 2012-2016
• ICT budget forecasts in Large Norwegian Healthcare providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Medium-sized Norwegian Healthcare providers - Estimated ICT budget breakdowns in 2013
• ICT budget forecasts in Small Norwegian Healthcare providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Belgian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Brazilian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Canadian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Dutch Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large French Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large German Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Mexican Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Spanish Healthcare Providers - Estimated ICT budget breakdowns in 2013